Reported cases of shingles—a viral condition characterized by a painful, blistering rash and severe nerve pain—have risen over the past two decades according to public health data. The infection stems from the reactivation of the varicella-zoster virus, the exact same pathogen responsible for chickenpox, which remains dormant in nerve tissue after initial childhood infection.
Understanding Shingles and Its Complications
According to the National Council on Aging (NCOA), approximately one in three Americans develops shingles during their lifetime, with nearly one million people affected annually in the United States. While early signs typically involve sensitive or tingling skin followed by a red, blistery rash that scabs over within seven to ten days, the health implications can extend far beyond initial skin irritation.
Roughly 10% to 18% of individuals who contract shingles experience long-term nerve pain known as postherpetic neuralgia (PHN), according to the NCOA. Additional severe complications documented by health agencies include pneumonia, hearing problems, encephalitis or brain inflammation, secondary bacterial infections, and, in rare instances, death.
Vaccination Recommendations and Efficacy
Health experts recommend the Shingrix recombinant zoster vaccine for adults aged 50 and older, since the risk of contracting shingles and suffering severe complications increases progressively with age. For younger populations, the NCOA notes that the two-dose vaccine is recommended for adults aged 19 and older who are immunocompromised.
Clinical data indicates that Shingrix provides robust protection against the virus. According to NCOA figures, the vaccine is more than 90% effective, specifically demonstrating 97% effectiveness in adults aged 50 through 69 and 91% effectiveness in adults aged 70 and older. Shingrix completely replaced the older Zostavax vaccine, which was discontinued in November 2020.
Patient Perspectives on Shingles Pain
Patients who have experienced the virus frequently describe severe physical discomfort. Amy-Sarah Marshall shared her motivation for getting immunized on the University of Virginia Health system’s Healthy Balance blog, noting that she chose not to wait after hearing stories about the intensity of shingles pain. Similarly, Paula Bourbon described her first outbreak on the Children’s Hospital of Philadelphia Parents PACK blog as feeling “like a lightning bolt hit my head,” noting that the rash spread from her scalp to her forehead and eyes before she was ever vaccinated.
Health experts emphasize that vaccination remains the only way to prevent the reactivation of the varicella-zoster virus and mitigating the risk of debilitating long-term nerve damage.
Keep reading